findmyKOL

Laura Jacobsen, MD

Enriched profile

Associate Professor, Department of Pediatrics · University of Florida

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Gainesville, FL · Southeast · United StatesSpecialtyPediatric EndocrinologyFocusDiabetes Management and Research+4
Active KOLfindmyKOL type: EliteLatest publication2026Online presenceverified 2026Payments2022–2025NIH funding2021–2026

Laura Jacobsen is Associate Professor, Department of Pediatrics at University of Florida. OpenAlex indexes 236 publications with 6,272 citations (h-index 39); ClinicalTrials.gov lists 4 registered studies with this person as an investigator.

Data verified 18 Oct 2026

Overview

Updated 18 Oct 2026

Laura Jacobsen, MD, is Associate Professor, Department of Pediatrics at University of Florida. The public record shows 236 publications with 6,272 citations (h-index 39), centered on Diabetes Management and Research, Diabetes and associated disorders, Pancreatic function and diabetes. It also documents an investigator role on 4 registered clinical trials, industry payments reported by 5 companies, 3 NIH-funded awards (2021–2026).

  • Most recent indexed publication: 2026 · Diabetes care
  • Top research focus: Diabetes Management and Research
  • 4 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 5 companies

Generated from the cited public record · current as of 18 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Type 1 Diabetes3 trialsMyotonia Congenita1 trialMyotonia1 trialType 2 Diabetes

Research focus

OpenAlex concept fingerprint
Diabetes Management and ResearchDiabetes and associated disordersPancreatic function and diabetesDiabetes Management and EducationT-cell and B-cell Immunology

Drugs & molecules

across trials, industry payments and publications
Tzieldgeneric · TeplizumabClinical trials—Industry payments13Publications—LeuprolideClinical trials—Industry payments1Publications—Tivdakgeneric · TisotumabClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
Insulet CorporationClinical trials—Industry payments12Sanofi Us Services Inc.Clinical trials—Industry payments7Sanofi-Aventis U.S. LLCClinical trials—Industry payments6University of FloridaClinical trials2Industry payments—Abbvie Inc.Clinical trials—Industry payments1City of Hope Medical CenterClinical trials1Industry payments—Pfizer Inc.Clinical trials—Industry payments1Rigshospitalet, DenmarkClinical trials1Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
236publications

Distinct works indexed by OpenAlex, matched via ORCID; 41 in PubMed.

6,272citations

Total citations across indexed works.

39h-index

Hirsch index (OpenAlex). i10-index 89.

Clinical & industry

trials, payments and federal funding
4clinical trials

Investigator role on registered studies.

View trials ↓
5companies · 2022–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
3NIH grants · 2021–2026

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 18 Oct 2026

Listed as an investigator on 4 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 18 Oct 2026

5 companies reported payments to CMS in program years 2022–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Hormonal (systemic)

    100%
    l-Thyroxine60.7%
    Levothyroxine Sodium100%
    Part D<11 patients
    l-Triiodothyronine39.3%
    Liothyronine Sodium100%
    Part D<11 patients

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 18 Oct 2026

3 NIH research awards on record, funded 2021–2026 per NIH RePORTER. The latest:

Congress activity

Updated 18 Oct 2026

34 congress contributions (2018–2025) across ADA, ENDO per OpenAlex. The most recent:

Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.

Publications

Updated 18 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 18 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Desmond Schatz82Emily Kristen Sims78Heba M. Ismail74MARIA JOSE REDONDO73Michael J. Haller66David D Cuthbertson66Andrea K. Steck62Jay M. Sosenko61Mark A. Atkinson53Helena Elding Larsson45Stephen S. Rich45Carmella Evans‐Molina43Linda Anne DiMeglio40Brandon M. Nathan40Jeffrey P. Krischer40Markus Lundgren39William Hagopian38Suna Önengüt-Gümüşcü37Åke Lernmark36Ingrid M. Libman35Ezio E. Bonifacio34Peter A. Gottlieb34Richard A. Oram33Suzanne Bennett Johnson33Brigitte I. Frohnert33Stephen Eric Gitelman32Patricia Gesualdo32Riitta Veijola31Jorma Toppari31Roy Tamura31Beena Akolkar30Todd M. Brusko30Kendra Vehik30John M. Wentworth30Kimberly A. Driscoll30Joanna L. Clasen30Falastin Salami30Katharina Warncke29Hemang M. Parikh29Mikael Knip28

Online presence

Updated 18 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/laura-jacobsen-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗

Mentions by others

where others cite or feature them
  • Other

    endo.pediatrics.med.ufl.edu/profile/jacobsen-laura

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →endo.pediatrics.med.ufl.edu ↗
  • Other

    immunology.ufl.edu/profile/jacobsen-laura

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →immunology.ufl.edu ↗
  • Other

    trialnet.org/node/696

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →trialnet.org ↗
  • Other

    ufhealth.org/doctors/laura-m-jacobsen/bio

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ufhealth.org ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 18 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances
  • TheSugarScience Podcast

    Episode 175, March 14, 2023: Emerging Biomarkers of Response to Immunotherapies

    2023
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →thesugarscience.podbean.com ↗

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.